Cancer papers

Glioblastoma (GBM) research papers

Papers tagged to Glioblastoma (GBM). Adjust filters if you want a narrower scope.

10 papersSorted by most recent
Peer-reviewedImpact 61

Topics

Not listed

Modality

Targeted therapy, Imaging

Study type

Not listed

Abstract

Abstract not available.

Authors

Zita Reisz, Nikhil Agarwal, Evangelos Anagnostou, Yasir A Chowdhury +10

AI-generated summary

Summary not available yet.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Evaluation of NETosis-related biomarkers in glioblastoma multiforme: PAD4 as a potent diagnostic predictor.
Journal of neuro-oncology • 2026-02-17 • DOI: 10.1007/s11060-026-05469-8
Peer-reviewedImpact 66

Topics

Diagnosis, Biology / Mechanism

Modality

Biomarker / Liquid biopsy, Imaging

Study type

Not listed

Abstract

Abstract not available.

Authors

Aykut İlikhan, Selda Taşdemir, Şükrü Oral, Ahmet Küçük +3

AI-generated summary

Summary not available yet.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Topics

Treatment, Biology / Mechanism

Modality

Targeted therapy, Imaging

Study type

Lab / Preclinical

Abstract

Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options. Tumor-associated astrocytes (TAAs) are crucial components of the GBM microenvironment, yet the contribution of alternative splicing (AS) in TAAs to tumor progression remains unclear. Transcriptomic and molecular analyses of GBM-associated astrocytes revealed…

Authors

Runxin Wu, Xiaozhou Yu, Xiao Song, Qiu He +7

AI-generated summary

Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoforms. reports: Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options. Tumor-associated astrocytes (TAAs) are crucial components of the GBM microenvironment, yet the contribution of alternative splicing (AS) in TAAs to tumor progression remains unclear. Transcriptomic and molecular analyses of GBM-associated astrocytes revealed a GBM-induced isoform switch in the RNA-binding protein Quaking (QKI) from the QKI-6 isoform to QKI-5 isoform.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Peer-reviewedImpact 71

Topics

Diagnosis

Modality

Imaging

Study type

Not listed

Abstract

Deploying pathology AI at individual hospitals faces challenges including limited cases and adapting pretrained models to local data. Brain tumor classification, with diverse diagnostic categories but few cases per institution, represents this challenge. Foundation models may offer a solution, but optimal transfer learning strategies…

Authors

Ken Enda, Yoshitaka Oda, Zen-Ichi Tanei, Kenichi Satoh +7

AI-generated summary

Transfer Learning Strategies for Pathological Foundation Models: A Systematic Evaluation in Brain Tumor Classification. reports: Deploying pathology AI at individual hospitals faces challenges including limited cases and adapting pretrained models to local data. Brain tumor classification, with diverse diagnostic categories but few cases per institution, represents this challenge. Foundation models may offer a solution, but optimal transfer learning strategies remain unclear.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Peer-reviewedImpact 71

Topics

Treatment, Diagnosis, Biology / Mechanism, Epidemiology

Modality

Biomarker / Liquid biopsy, Imaging

Study type

Lab / Preclinical, Observational

Abstract

Pediatric and adult glioblastomas (GBM) represent biologically distinct entities requiring age-tailored therapeutic strategies. However, rapid and non-invasive methods to distinguish these molecular subtypes remain an unmet clinical need. This study evaluates the potential of confocal Raman spectroscopy combined with deep learning as a label-free…

Authors

Lennard M Wurm, Björn Fischer, Volker Neuschmelting, Roland Goldbrunner +7

AI-generated summary

Spectral discrimination of pediatric SF188 and adult glioblastoma stem cells by deep learning-enhanced Raman profiling. reports: Pediatric and adult glioblastomas (GBM) represent biologically distinct entities requiring age-tailored therapeutic strategies. However, rapid and non-invasive methods to distinguish these molecular subtypes remain an unmet clinical need. This study evaluates the potential of confocal Raman spectroscopy combined with deep learning as a label-free diagnostic tool to differentiate pediatric from adult GBM based on intrinsic biochemical fingerprints.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Differential migration mechanics and immune responses of glioblastoma subtypes
cancer biology • 2025-09-22 • DOI: 10.1101/2022.06.26.497270
PreprintImpact 46

Topics

Biology / Mechanism, Outcomes / Survival

Modality

Immunotherapy, Cell therapy, Imaging

Study type

Lab / Preclinical

Abstract

Glioblastoma remains a deadly cancer driven in part by invasion of tumor cells into the brain. Transcriptomic analyses have identified distinct molecular subtypes, but mechanistic differences that account for clinical differences are not clear. Here, we show that, as predicted by the motor-clutch model…

Authors

Shamsan, G. A., Liu, C. J., Braman, B. C., Li, R. +14

AI-generated summary

Differential migration mechanics and immune responses of glioblastoma subtypes reports: Glioblastoma remains a deadly cancer driven in part by invasion of tumor cells into the brain. Transcriptomic analyses have identified distinct molecular subtypes, but mechanistic differences that account for clinical differences are not clear. Here, we show that, as predicted by the motor-clutch model of cell migration, mesenchymal glioma cells are more spread, generate larger traction forces, and migrate faster in brain tissue compared to proneural cells. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: bioRxiv (not peer reviewed).

BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune CheckpointSensitivity in BRAFV600E-mutant Glioma
cancer biology • 2025-04-01 • DOI: 10.1101/2023.02.03.526065 • Published in 10.1016/j.xcrm.2025.102183
PreprintImpact 55

Topics

Treatment, Outcomes / Survival

Modality

Immunotherapy, Targeted therapy, Cell therapy, Biomarker / Liquid biopsy, Imaging

Study type

Lab / Preclinical

Abstract

Resistance to BRAF plus MEK inhibition (BRAFi+MEKi) in BRAFV600E-mutant gliomas drives rebound, progression, and high mortality, yet it remains poorly understood. This study addresses the urgent need to develop treatments for BRAFi+MEKi-resistant glioma in novel mouse models and patient-derived materials. BRAFi+MEKi reveals glioma plasticity…

Authors

Xing, Y. L., Panovska, D., Park, J.-W., Grossauer, S. +23

AI-generated summary

BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune CheckpointSensitivity in BRAFV600E-mutant Glioma reports: Resistance to BRAF plus MEK inhibition (BRAFi+MEKi) in BRAFV600E-mutant gliomas drives rebound, progression, and high mortality, yet it remains poorly understood. This study addresses the urgent need to develop treatments for BRAFi+MEKi-resistant glioma in novel mouse models and patient-derived materials. BRAFi+MEKi reveals glioma plasticity by heightening cell state transitions along glial differentiation trajectories, giving rise to astrocyte- and immunomodulatory oligodendrocyte (OL)-like states. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: bioRxiv (not peer reviewed).

Topics

Treatment, Diagnosis

Modality

Immunotherapy, Surgery, Biomarker / Liquid biopsy, Imaging

Study type

Not listed

Abstract

BackgroundWe investigated a novel therapeutic approach to glioblastoma (GBM) that targets cell-free chromatin particles (cfChPs) that are released from dying GBM cells and aggravate the oncogenic phenotype of living GBM cells. cfChPs can be deactivated by oxygen radicals (OR) generated upon admixing the nutraceuticals…

Authors

Bandiwadekar, C., Devi, N. L., Moiyadi, A. V., Singh, V. +7

AI-generated summary

Attenuation of malignant phenotype of glioblastoma following a short course of the pro-oxidant combination of Resveratrol and Copper reports: BackgroundWe investigated a novel therapeutic approach to glioblastoma (GBM) that targets cell-free chromatin particles (cfChPs) that are released from dying GBM cells and aggravate the oncogenic phenotype of living GBM cells. cfChPs can be deactivated by oxygen radicals (OR) generated upon admixing the nutraceuticals Resveratrol (R) and Copper (Cu). Oral administration of R-Cu leads to generation of OR which are readily absorbed to deactivate cfChPs. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: medRxiv (not peer reviewed).

YAP controls cell migration and invasion through a Rho-GTPase switch
cancer biology • 2025-02-21 • DOI: 10.1101/602052
PreprintImpact 38

Topics

Biology / Mechanism, Outcomes / Survival

Modality

Biomarker / Liquid biopsy, Imaging

Study type

Not listed

Abstract

Delineating the mechanisms controlling the invasive spread of non-diseased and transformed cells is central to understanding diverse processes including cancer progression. Here, we found that Yes-associated protein (YAP), a central transcriptional regulator implicated in controlling organ and body size, modulated a Rho-GTPase switch that…

Authors

Shah, S. R., Ren, C., Tippens, N. D., Park, J. +9

AI-generated summary

YAP controls cell migration and invasion through a Rho-GTPase switch reports: Delineating the mechanisms controlling the invasive spread of non-diseased and transformed cells is central to understanding diverse processes including cancer progression. Here, we found that Yes-associated protein (YAP), a central transcriptional regulator implicated in controlling organ and body size, modulated a Rho-GTPase switch that drives cellular migration by transactivating the Rac1-GEF protein TRIO through direct modulation of its intronic enhancer. Additionally, YAP and TRIO may promote invasive behavior through putative crosstalk with STAT3 signaling, a potential downstream target. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: bioRxiv (not peer reviewed).

Causal associations between gut microbiota and cancers
oncology • 2025-02-20 • DOI: 10.1101/2025.02.17.25322359
PreprintImpact 42

Topics

Treatment, Diagnosis, Biology / Mechanism, Outcomes / Survival, Prevention / Risk

Modality

Imaging

Study type

Review / Meta-analysis

Abstract

BackgroundEmerging evidence suggests that the gut microbiota is associated with various cancer-related outcomes. Recent studies using Mendelian randomization (MR) have indicated a causal relationship between gut microbiota and several types of cancer. However, these conclusions remain controversial. To clarify this relationship, we conducted a…

Authors

Yue, z., yan, j., Shen, l., Zhao, c. +8

AI-generated summary

Causal associations between gut microbiota and cancers reports: BackgroundEmerging evidence suggests that the gut microbiota is associated with various cancer-related outcomes. Recent studies using Mendelian randomization (MR) have indicated a causal relationship between gut microbiota and several types of cancer. However, these conclusions remain controversial. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: medRxiv (not peer reviewed).